NCT04227730

Brief Summary

Group B Streptococcus (GBS), is a facultative gram positive diplococcus originally known for causing bovine mastitis and was not demonstrated to be a human pathogen until 1938. In the 1970s, GBS emerged as the leading cause of neonatal morbidity and mortality, with a frequency of 2-3 cases per 1,000 live births and case-fatality ratios as high as 50%

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jun 2019

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2019

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

January 10, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 14, 2020

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2020

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2020

Completed
Last Updated

March 31, 2022

Status Verified

March 1, 2022

Enrollment Period

1.6 years

First QC Date

January 10, 2020

Last Update Submit

March 17, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • prevalence of GBS in Fayoum

    Percentage of maternal GBS infection and its reflection on neonatal infection

    one year

Secondary Outcomes (1)

  • improve and simplify the diagnosis of GBS

    one year

Study Arms (2)

group A

group A (+ve GBS) 300 pregnant of gestational age 35-37 weeks were screened by a group B streptococcal (GBS) conventional PCR assay. Patients who were followed till delivery without prolonged rupture of membrane were eligible to enter the study and details with regard to labor and delivery were recorded. Infant data were also recorded.

Diagnostic Test: culture and PCR for group B streptococcus

group B

group B (-ve GBS) 300 pregnant of gestational age 35-37 weeks were screened by a group B streptococcal (GBS) conventional PCR assay. Patients who were followed till delivery without prolonged rupture of membrane were eligible to enter the study and details with regard to labor and delivery were recorded. Infant data were also recorded.

Diagnostic Test: culture and PCR for group B streptococcus

Interventions

all participants were evaluated by vaginorectal specimens for the detection of GBS, The swabs are placed in Amies transport medium and sent to the microbiology laboratory for testing by conventional PCR assay.

group Agroup B

Eligibility Criteria

Age18 Years - 46 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

pregnant females 35-37 weeks of gestational age attending the antenatal outpatient clinic at AlFayom University Hospital. All participants were screened by a group B streptococcal (GBS) conventional PCR assay. Patients who were followed till delivery without prolonged rupture of membrane were eligible to enter the study and details with regard to labor and delivery were recorded delivery was conducted at AlFayom university hospital. Infant data were also recorded.

You may qualify if:

  • pregnant females 35-37 weeks of gestational age Patients who were followed till delivery without prolonged rupture of membrane

You may not qualify if:

  • patients lost follow up and or had prolonged rupture of membrane\>12 hours

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

sahar M.Y elbaradie

Al Fayyum, Egypt

Location

MeSH Terms

Conditions

Streptococcal Infections

Condition Hierarchy (Ancestors)

Gram-Positive Bacterial InfectionsBacterial InfectionsBacterial Infections and MycosesInfections
0

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
associate Professor

Study Record Dates

First Submitted

January 10, 2020

First Posted

January 14, 2020

Study Start

June 1, 2019

Primary Completion

December 30, 2020

Study Completion

December 31, 2020

Last Updated

March 31, 2022

Record last verified: 2022-03

Locations